Morgan Stanley Maintains Overweight on Haleon, Raises Price Target to $10.95
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Rashad Kawan maintains an Overweight rating on Haleon (NYSE:HLN) and raises the price target from $9.9 to $10.95.
September 20, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has reaffirmed its Overweight rating on Haleon and increased the price target from $9.9 to $10.95, indicating a positive outlook.
The increase in price target from $9.9 to $10.95 by Morgan Stanley suggests a positive outlook for Haleon, likely boosting investor confidence and potentially leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100